Applied Research Investments’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,218
Closed -$893K 13
2022
Q2
$893K Sell
3,218
-195
-6% -$58.6K 3.95% 11
2022
Q1
$1.15M Sell
3,413
-11,866
-78% -$4M 3.43% 12
2021
Q4
$6.33M Buy
15,279
+2,469
+19% +$900K 2.09% 19
2021
Q3
$4.1M Buy
12,810
+10,873
+561% +$3.54M 1.36% 26
2021
Q2
$571K Hold
1,937
0.2% 39
2021
Q1
$535K Sell
1,937
-930
-32% -$240K 0.2% 42
2020
Q4
$749K Buy
2,867
+285
+11% +$68.3K 0.32% 42
2020
Q3
$584K Sell
2,582
-1
-0% -$229 0.33% 40
2020
Q2
$555K Buy
+2,583
New +$489K 0.49% 35

Other funds holding ACN

Applied Research Investments's ACN Position: Q3 2022 in Review

Applied Research Investments sold out of Accenture (ACN) in Q3 2022, closing a stake of 3,218 shares — an estimated $893K sold.

Applied Research Investments first reported a position in ACN in Q2 2020 and held it in 9 quarters. The position peaked at $6.33M in Q4 2021. 1,941 funds tracked by Wall St. Rank hold ACN as of Q3 2022.

  • Applied Research Investments reported no remaining Accenture position as of Q3 2022 after selling out during the quarter.
  • Applied Research Investments sold 3,218 Accenture shares in Q3 2022, an estimated $893K.
  • Applied Research Investments first reported a position in Accenture in Q2 2020 and held it in 9 quarters.
  • Applied Research Investments's Accenture position peaked at $6.33M in Q4 2021.
  • 1,941 funds tracked by Wall St. Rank held Accenture as of Q3 2022.

Based on Applied Research Investments's 13F filing for Q3 2022, filed 14 Nov 2022.